Clinical Trial Update: Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating sequential anti-angiogenic therapy after immunotherapy in advanced biliary tract cancers, including cholangiocarcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Bile Duct Carcinoma, Gall Bladder Cancer | Phase 2 | Status: RECRUITING